St2 antigen binding proteins
US-2024368292-A1 · Nov 7, 2024 · US
Peptide analogues comprising at least one type of aminoacylaza-$g(b)<sp>3</sp>and the use thereof, in particular for therapy
US9017673B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9017673-B2 |
| Application number | US-56016304-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 11, 2004 |
| Priority date | Jun 11, 2003 |
| Publication date | Apr 28, 2015 |
| Grant date | Apr 28, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-β 3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of systemic lupus erythematosus, comprising administering to a patient in need thereof a pharmaceutically acceptable amount of a hybrid peptide containing at least one aza-β 3 aminoacyl residue, selected from the group consisting of: a residue corresponding to formula (A) when the residue is situated at the N-terminal position,…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9017673B2 cover?
- The object of the present invention is analogues of peptides or parent proteins, these peptide analogues, comprising at least one aza-β 3 aminoacyl residue, and also their uses in pharmaceutical compositions or for the diagnosis of pathologies wherein the aforesaid peptides or parent proteins are involved.
- Who is the assignee on this patent?
- Baudy Michèle Floc H, Busnel Olivier, Muller Sylviane, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K39/395. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).